Univ. Prof. Dr. Steffen Hering

University of Vienna

 Anniversary brochure contribution by Steffen Hering

Researcher's Profile

Research interests: 

  • Molecular Pharmacology of ion channels
  • Screening technologies
  • Subunit-dependent pharmacology of novel GABAA receptor ligands (in vitro, in vivo)


Personal Data:

Date of birth: 01.09.1954
Nationality: Germany



1973-19792nd Medical Institute, Moscow, Biophysics and Medicine
1983Dissertation for the degree Doctor of Medicine ("doctor medicinae") at the Academy of Sciences Berlin
1983Graduation: Specialist (medical) in physiology
1988Habilitation: "doctor scientiae medicinae" [Dr. sc. med.]
1995Habilitation (venia legendi) in Pharmacology and Toxicology at the University Innsbruck


 Academic Positions:

1988-1989Welcome Trust Research Fellow at St. George's Hospital, London, Department of Clinical and Experimental Pharmacology (Chairman: Prof. T.B. Bolton)
1990-1991Research Assistant at the Max-Delbrück-Center for Molecular Medicine
August 1991University Lecturer at the Institute for Biochemical Pharmacology, University Innsbruck (Chairman: Prof. Glossmann)
1998Assistant Professor at the Institute for Biochemical Pharmacology, University Innsbruck (Chairman: Prof. Glossmann)
February 2003 - September 2019Full Professor, Chairman of the Department of Pharmacology and Toxicology, University of Vienna


Ongoing MolTag research projects as supervisor:

  • Bozhidar BALTOV: 2D and 3D cultures of stem cell derived cardiac cells on patterned cell culture surfaces for cardiotox studies
  • Michael NETZER: A novel drug sreening technology for studying acute and chronic drug toxicity in 2D and 3D stem stell derived cardiac cells


Completed projects as supervisor:

  • Angela SCHÖFFMANN: Piperine Derivatives as New GABAA Receptor Ligands, finished 08/2015
  • Juliane HINTERSTEINER: In vivo Characterization of Natural Product GABAA Modulators and their Derivatives, finished 11/2015
  • Denise LUGER: Molecular determinants of anxiolytic and anticonvulsive properties of valerenic acid and derivatives; finished 11/2015
  • Marco STADLER: Investigating a potentially synergistic anticonvulsant effect of dehydroabietic acid and derivatives, finished 03/2019
  • Stanislav ANDRANOVITS: Gating determinants of Cav1.2 L-type calcium channel, finished 07/2019
  • Aleksandra GARIFULINA: Modulation of GABAA Receptors by Low-Molecular-Weight Compounds, finished 03/2024


Completed projects as co-supervisor:

  • Laurin WIMMER: Synthesis of bioactive molecules for the investigation of ion channels and transporters, finished 02/2016
  • Priyanka SAXENA: Probing the architecture of hERG potassium channel with drugs; finished 11/2015
  • Daria GOLDMANN: Selectivity Profiling of Ligands towards GABAA and TRPV1 Receptors, finished 09/2015